Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01931852 · ClinicalTrials.gov registry record · NA
Cardiac Magnetic Resonance Imaging Strategy for the Management of Patients With Acute Chest Pain and Detectable to Elevated Troponin
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 312
- Enrollment target
NCT01931852 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 312 participants.
The verdict
NCT01931852, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 312 participants
- Enrollment target
Study Summary
The broad, long-term objective is to improve outcomes by optimizing healthcare delivery processes for patients with detectable to elevated serum troponin. This clinical trial involving emergency department (ED) patients with intermediate to high-risk chest pain and detectable to minimally elevated serum troponin within 6 hours of evaluation.
Interventions
- PROCEDURE Cardiac MRI
- OTHER ACC/AHA Guideline adherent care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 312 participants |
| Start Date | 2013-09 |
| Est. Completion | 2020-10-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01931852
The ClinicalTrials.gov registry entry for NCT01931852 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 312 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cardiac MRI is the first listed.
NCT01931852 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01931852 about?
NCT01931852 is a clinical study titled "Cardiac Magnetic Resonance Imaging Strategy for the Management of Patients With Acute Chest Pain and Detectable to Elevated Troponin". The broad, long-term objective is to improve outcomes by optimizing healthcare delivery processes for patients with detectable to elevated serum troponin. This clinical trial involving emergency department (ED) patients with intermediate to high-risk chest pain and detectable to minimally elevated s...
What is the current status of trial NCT01931852?
This trial is currently completed. It is a NA study. The enrollment target is 312 participants. The study started on 2013-09. Estimated completion is 2020-10-02.
What interventions are being tested in trial NCT01931852?
The interventions under investigation include: Cardiac MRI (PROCEDURE), ACC/AHA Guideline adherent care (OTHER).
Who is sponsoring clinical trial NCT01931852?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.